New York, NY -- (SBWIRE) -- 03/21/2013 -- StockRunway.com issues special report on the Morning Winners – Affymax, Inc. (NASDAQ:AFFY), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), SUPERVALU INC. (NYSE:SVU), ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)
Affymax, Inc. (NASDAQ:AFFY) surged +15.07% to $1.45 in the mid-day with the total traded volume of 16.15 million shares. Its fifty two week range was $1.01-$27.74. The total market capitalization remained $53.89million.
For How Long AFFY will Fight for Profitability? Read This Trend Analysis report
AFFY is ahead its 52 week low with 43.55% and its last month price volatility remained 18.88%. Its beta coefficient was 1.15 with a target price of $7.83. AFFY has insider ownership of 0.54% with its institutional ownership remained 90.48%. Company’s current year earnings per share reduced with 220.74% while the five year EPS growth rate was 7.00%.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported the gain of +27.55% to $8.46 in the mid-day trading session and its total traded volume was 12.75 million shares. ACAD has outstanding shares of 78.76 million with the total market cap of 682.04 million and its beta value stands at 2.75 times. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders.
For How Long ACAD’s Gloss will Attract Investors? Find out via this report
SUPERVALU INC. (NYSE:SVU) shares went up +10.02% to $4.61 during the mid-day trading hours and its total traded volume was 9.70 million shares more than the average volume of 4.94 million. SVU has market cap of 984.04 million. Stock price 52 weeks high was $6.78 and 52 weeks low price was $1.68. SUPERVALU INC. (SUPERVALU) is a United States grocery channel. It operates in two segments: Retail food and Independent business.
Will SVU Continue To Move Higher? Find Out Here
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) gained +3.53% to $18.47 in the mid-day trading hours with the total traded volume of 2.94 million shares more than the average volume of 1.27 million. Stock price 52 weeks high was $19.53 and 52 weeks low price was $7.02. Isis Pharmaceuticals, Inc. develops therapeutic drugs inhibiting cell protein synthesis.
Why Should Investors Buy ISIS After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you&aposre new to penny stocks or a seasoned veteran, you&aposll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway&aposs service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
For more information on this press release visit: http://www.sbwire.com/press-releases/morning-winners-affymax-inc-nasdaqaffy-acadia-pharmaceuticals-inc-supervalu-inc-isis-pharmaceuticals-inc-226900.htm